Synthetic Biology Market By Product Type (Oligonucleotides, Enzymes, Synthetic Genes & Proteins, Chassis Organisms & Microbes, and Others), By Application (Healthcare & Medicine, Agriculture, Industrial Biotechnology, Environmental, Food, and Others), By Technology (Gene Synthesis, Genome Engineering, Cellular Engineering, Bioprocessing, DNA Sequencing, and Others), and By End-user (Biotechnology Companies, Agricultural Companies, Research & Academic Institutions, Environmental & Waste Management Companies)Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The Synthetic Biology market accounted for USD 18.25 Billion in 2024 and is expected to reach USD 145.9 Billion by 2035, growing at a CAGR of around 20.8% between 2025 and 2035.  The synthetic biology market focuses on developing the application of engineering principles for biotechnology. It aims at developing new biological parts, constructing them, and then a new organism for better living. This multidisciplinary field is creating some innovative solutions for areas such as healthcare, agriculture, energy, and environmental sustainability.

The subsectors in the synthetic biology market include gene editing, microorganisms, biofuels, and biopharmaceuticals. Advances in genetic engineering and CRISPR technology are boosting the growth of the market. Synthetic biology is set to revolutionize industries, from improving production processes to developing new therapies and sustainability. Therefore, the market will grow enormously with the rising demand for biotechnology solutions and innovation. 

Report Scope:

Market Dynamics

Growing Demand for Sustainable and Efficient Industrial Processes Accelerates Adoption of Synthetic Biology

The increasing demand for chemicals, agriculture, and food production through efficient industrial processes is driving the growth of synthetic biology. Companies can optimize production yields and minimize waste while enhancing sustainability by utilizing synthetic biology. These technologies provide a greener and more cost-effective approach to bio-manufacturing chemicals, biofuels, and food ingredients, resulting in a more efficient process overall.

The contributions of synthetic biology to agricultural practice in terms of crop yields, pest resistance, and resistance to climate change help ensure food security. As industries seek out means to achieve their sustainability requirements, the role of synthetic biology in industrial process transformation is emerging to be more crucial.

Furthermore, the potential to create custom organisms to suit specific industrial applications has opened new pathways for innovation and efficiency in production. Synthetic biology could provide a way to reduce the carbon footprint of traditional manufacturing amid the tightening of global environmental regulations.

Surging Demand for Personalized Medicines and Biologics Fueling Growth in Synthetic Biology

The rising demand for biopharmaceuticals is propelling growth in synthetic biology. There is an increasing need for drugs tailored to an individual’s genetic makeup. As the generation of biologics in the form of vaccines and therapeutic proteins is on the increase, it directly translates into benefits from synthetic biology methods and the technologies they develop. These could result in more efficient, targeted therapies with better outcomes.

Synthetic biology is poised to play a significant role in the biopharmaceutical sector, as it will advance precision medicine, increase the rate of drug production, and simultaneously decrease costs. This approach reshapes the future of health. Moreover, the COVID-19 outbreak made it clear that it required vaccines to be prepared on time, which has further necessitated the use of synthetic biology. With evolving global health challenges, synthetic biology will continue to play a key role in solving new diseases and providing timely medical solutions.

Biosafety Concerns and Unintended Consequences Restrict Growth of Synthetic Biology Market

Biosafety is a major limitation in the growth of the synthetic biology market. The creation of synthetic organisms raises concerns about unintended consequences, such as environmental hazards or health risks. There are concerns that engineered organisms may unpredictably interact with natural ecosystems, leading to biodiversity loss, contamination, and the spread of harmful traits like antibiotic resistance.

Regulatory bodies are conservative, enforcing very stringent rules and safety measures to address these risks, which will inevitably hinder innovation and commercialization. The public's safety and ethical concerns add another layer of complexity to the advancement of synthetic biology technologies, requiring continued research into robust containment and monitoring systems.

Leveraging Synthetic Biology for Effective Waste Reduction and Bioremediation

Synthetic biology can focus on the engineering of organisms that can degrade environmental pollutants and waste. With pollution levels at a continuously escalating stage, bioremediation offers an environmentally friendly means of cleaning up oil spills, heavy metals, plastics, and many more. The United Nations Environment Programme (UNEP) states that plastic waste totals about 8 million tons annually being transported into oceans requiring urgent resolution via biological agents.

Additionally, the United States Environmental Protection Agency (EPA) estimated that thousands of 10,000 exist in waste facilities in the U.S. only, synthetic biologists also advance the manufacture of those microbial agents with the property to degrade toxins. The above innovation addresses environmental issues besides contributing to the growing need for sustainable, cost-effective control of pollution, and is thus driving market growth.

Synthetic Biology in Agriculture Promoting Food Security through Genetically Engineered Crops and Sustainable Solutions

Synthetic biology in agriculture is revolutionizing food production with solutions for the increase in global food demand. Genetically modified crops will be designed to resist adverse weather, pests, and diseases, among others, thereby increasing yields and reducing dependence on chemicals used as pesticides. Pest-resistant plants can eventually lead to sustainable farming with reduced ecological impacts.

Additionally, synthetic biology also allowed the creation of innovative fertilizers, which enables optimizing the delivery of fertilizing microelements and minimizing waste. With populations rapidly increasing across the globe, the use of synthetic biology in developing crop productivity in efficient ways is bound to make it an even more highly needed application.

Industry Experts Opinion

“The expansion of our synthetic biology manufacturing operations adds significant capacity for IDT and lays the foundation for the future growth of our synthetic biology product portfolio.”

• Demaris Mills, President, Integrated DNA Technologies (IDT)

Segment Analysis

Based on the product type, the Synthetic Biology market has been classified into oligonucleotides, enzymes, synthetic genes & proteins, chassis organisms & microbes, and others. Synthetic genes and proteins lead the market as they play a crucial role in drug development, gene therapies, and biologics such as antibodies and vaccines. They provide advancement in personalized medicine, precision treatments, and biopharmaceutical production which are in great demand. Their applications also cut across industries, such as health, agriculture, and industrial biotechnology, driving significant market growth. 

Based on the application, the Synthetic Biology market has been classified into healthcare & medicine, agriculture, industrial biotechnology, environmental, food, and others. The Healthcare & Medicine segment leads the market, which is largely driven by the increased demand for personalized medicines, gene therapies, and biologics. Advances in gene editing technologies like CRISPR have been made to formulate targeted therapies against genetic defects, cancer, and infectious diseases, thus making way for a promising market. Market growth is also supplemented by increasing research interest in next-generation drugs, vaccines, and diagnostics.

Regional Analysis

North America is the largest region for the synthetic biology market, which will be primarily driven by the United States. Substantial investments in research and development are available in this region, with many universities and research institutes as well as numerous biotech companies focused on these innovations in synthetic biology. The US currently leads in the use of gene editing technologies like CRISPR, gene synthesis, and biopharmaceutical production. Government initiatives and investments. North America has one of the best biotechnology regulatory frameworks and infrastructural setups for the market. Personalization medicine and biologics are now in huge demand, thereby driving the demand for the synthetic biology market.

The Asia-Pacific region is going to be the fastest-growing market because of rapid progress in the biotechnology field and investing heavily in research and development work. China, India, and Japan are moving forward significantly in synthetic biology applications in the healthcare, agriculture, and environmental sectors. Increasing population in the region and an immediate requirement for sustainable solutions in agriculture and energy are driving adoption in synthetic biology. Healthcare, expanding in Asia-Pacific and further improving regulatory frameworks, offers favorable market conditions. High-technology growth in the Asia-Pacific region, coupled with government support, is set to continue driving its synthetic biology growth.  

Competitive Landscape

The synthetic biology market is highly competitive with top leaders in innovation and product development such as Thermo Fisher Scientific, Ginkgo Bioworks, GenScript, Lonza Group, Illumina, and Codexis. These organizations focus on developing gene synthesis, genome engineering, and biomanufacturing technologies targeting various sectors, including the health and agricultural industries as well as industrial biotechnology.

It can be noted that recent expansion involves the collaboration between Ginkgo Bioworks and BASF to advance a solution for sustainable agriculture, besides which, Illumina drives further growth in genomic sequencing while helping play a pivotal role in the healthcare applications of synthetic biology. These developments mark a growing demand for sustainable solutions, which are innovative as well as dynamic in character for the synthetic biology market.

Synthetic Biology Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In November 2024, Asymchem, one of the world's leading contract development and manufacturing organizations (CDMO), has recently developed an AI platform focused on key challenges in protein design. The newly developed artificial intelligence platform is known as STAR (Sequence Recommendation via Artificial Intelligence). Asymchem's Center of Synthetic Biology Technology (CSBT) and AI team successfully developed this innovative platform.
• In October 2024, bit. bio, the leader in coding human cells for novel cures and a pioneer in synthetic biology, announced that it has successfully defended its foundational European patent for the opti-ox technology - a breakthrough that has enabled the deterministic forward programming of PSCs, including iPSCs.

Report Coverage:

By Product Type

• Oligonucleotides
• Enzymes
• Synthetic Genes & Proteins
• Chassis Organisms & Microbes
• Others

By Application

• Healthcare & Medicine
• Agriculture
• Industrial Biotechnology
• Environmental
• Food
• Others

By Technology

• Gene Synthesis
• Genome Engineering
• Cellular Engineering
• Bioprocessing
• DNA Sequencing
• Others

By End-user

• Biotechnology Companies
• Agricultural Companies
• Research & Academic Institutions
• Environmental & Waste Management Companies 

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Thermo Fisher Scientific, Inc.
• DuPont de Nemours, Inc.
• GenScript Biotech Corporation
• Lonza Group
• Illumina, Inc.
• Regeneron Pharmaceuticals, Inc.
• Ginkgo Bioworks, Inc.
• Zymergen, Inc.
• Synthetic Genomics, Inc.
• Arzeda Corporation
• Codexis, Inc.
• Amyris, Inc.
• ExxonMobil Bioengineering
• Novozymes A/S
• Agilent Technologies, Inc.

Frequently Asked Questions (FAQs)